Lataa...
Fenfluramine-induced gene dysregulation in human pulmonary artery smooth muscle and endothelial cells
Fenfluramine is prescribed either alone or in combination with phentermine as part of Fen-Phen, an anti-obesity medication. Fenfluramine was withdrawn from the US market in 1997 due to reports of heart valvular disease, pulmonary arterial hypertension, and cardiac fibrosis. Particularly, idiopathic...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications & Media Pvt Ltd
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3224433/ https://ncbi.nlm.nih.gov/pubmed/22140631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2045-8932.87310 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|